Navigation Links
Safeguards needed for tissue donors
Date:1/28/2013

Donors to biobanks vast collections of human tissue samples that scientists hope will lead to new treatments for diseases have a right to basic information about how their donations may be used, a Michigan State University ethicist argues in a new paper.

The idea behind biobanks is that a repository with hundreds of thousands of samples, each linked to medical records and other health information, can yield discoveries smaller data sets can't match. Once samples are collected, researchers in many fields can use the data repeatedly.

"More and larger biobanks are in many ways the future of health research," said Tom Tomlinson, director of MSU's Center for Ethics and Humanities in the Life Sciences. "Their rise as a research tool means that sooner or later probably sooner all of us will be participating in research that we know nothing whatsoever about."

Ethicists have typically viewed biobank donations through the lens of risk: Once someone has given a tissue sample and all identifying information is removed, later research risks no harm to them. Since they no longer need protection, donors usually sign blanket consent forms and receive no updates about how the tissue is used.

But people make donations in the hope of doing good, giving them an ongoing moral stake in what happens to their tissue samples, Tomlinson writes in the Hastings Center Report, a leading bioethics journal.

"Donors should have the information they need to decide if there are moral risks involved that might not be worth taking," he said.

For instance, surveys have found that some people may not donate to publicly funded biobanks if the research would lead to private commercial gain. Others may not want to be involved in research on controversial issues like cloning, or studies that reinforce negative racial stereotypes.

"It's hard to tell a person exactly how their donation will be used," Tomlinson said, "but what you can tell them is the range of uses to which it might be put."

Tomlinson offers specific steps biobanks should take to protect donors' rights. Among them:

  • Donors should get ongoing summaries of research projects, written in plain language.

  • Biobanks should inform donors when their tissue might be used in potentially controversial research.

  • Data-management systems should be in place to let donors withdraw their samples at any time if they take issue with the kinds of research the biobank supports.


'/>"/>

Contact: Andy McGlashen
andy.mcglashen@cabs.msu.edu
517-355-5158
Michigan State University
Source:Eurekalert  

Related biology news :

1. Increasing water scarcity in Californias Bay-Delta will necessitate trade-offs; hard decisions needed to balance various environmental risks
2. Urgent research needed to determine most effective follow-up care for lung cancer patients
3. Report addresses challenges in implementing new diagnostic tests where they are needed most
4. Bigger refuges needed to delay pest resistance to biotech corn
5. Vaccine and antibiotics stabilized so refrigeration is not needed -- NIH study
6. No matter the drilling method, natural gas is a much-needed tool to battle global warming
7. Caution needed with new greenhouse gas emission standards
8. Citizen scientists needed for SF States ZomBee Watch
9. Continuing management needed for most threatened and endangered species
10. Major changes needed to protect Australias species and ecosystems
11. Greater effort needed to move local, fresh foods beyond privileged consumers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Safeguards needed for tissue donors
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, ... studies in healthy volunteers of a novel calcium ... treat acute pancreatitis. Acute pancreatitis, ... a mild disorder, but can be very serious.  In ... and sepsis, where extended hospital stays, time in ...
(Date:1/3/2017)... Jan. 3, 2017 Onitor, provider of digital ... Onitor Track, an innovative biometric data-driven program designed to ... month at the 2017 Consumer Electronics Show (CES) in ... In the U.S., the World Health Organization (WHO), have ... of adults who are overweight or obese. WHO also ...
(Date:12/19/2016)... 19 de diciembre de 2016  Mosaic Biomedicals SL anunció hoy ... de MSC-1, un anticuerpo humanizado que se espera comenzar a utilizar ... múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el primer ... leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos tumores ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ANNAPOLIS, Md. and GAITHERSBURG, ... Inc. (NYSE MKT: PIP) and Altimmune, Inc., a ... the signing of a definitive agreement for the ... transaction. Altimmune,s current investors include Novartis Venture Fund, ... company will be a fully-integrated and diversified immunotherapeutics ...
(Date:1/19/2017)... ... January 18, 2017 , ... ... engineers, and scientists from around the world, was today awarded the "Best Science ... is based entirely on merit and decided upon by a dedicated team of ...
(Date:1/19/2017)... -- Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a U.S. ... and inoperable solid tumor cancers, announced today that Dr. ... Bio, will present at the Phacilitate Immunotherapy World Conference ... Hotel in Miami, Florida . ... Therapeutic Approaches – Expanding the Reach of Cancer Immunotherapy ...
(Date:1/18/2017)... PUNE, India , January 18, 2017 According to ... Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, ... market is expected to reach USD 739.9 Million by 2021 from USD 557.1 ... Continue Reading ... MarketsandMarkets Logo ...
Breaking Biology Technology: